Description
erbitox lv 4,ERBITUX is indicated, in combination with encorafenib, for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E mutation, as detected by an FDA .
Beige and white GG Supreme canvas
ERBITUX
Gold-toned hardware
Erbitox LV 4
Double G
Inside: 1 open pocket
Erbitux Stage 4 — Cancer Survivors Network
Chain top handle with 7″ drop
Top zip closure
ERBITUX
7.2″W x 1.4″H x 2.1″D
Weight: 0.2lbs approximately
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS